Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells
Stella Cascioferro, Giovanna Li Petri, Barbara Parrino, et al.
European Journal of Medicinal Chemistry (2020) Vol. 189, pp. 112088-112088
Open Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

<p>Blocking circ_0013912 Suppressed Cell Growth, Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells in vitro and in vivo Partially Through Sponging miR-7-5p</p>
Weisheng Guo, Lin Zhao, Guangya Wei, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 7291-7303
Open Access | Times Cited: 21
A novel series of benzothiazepine derivatives as tubulin polymerization inhibitors with anti-tumor potency
Bin Wang, Liren Wang, Lulu Liu, et al.
Bioorganic Chemistry (2021) Vol. 108, pp. 104585-104585
Closed Access | Times Cited: 18
FAK Inhibitors As Promising Anticancer Targets: Present and Future Directions
Muhamad Mustafa, Amer Ali Abd El‐Hafeez, Dalia A Abdelhafeez, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 18, pp. 1559-1590
Open Access | Times Cited: 15
Design, synthesis, and antibacterial activity of a new series of ciprofloxacin-thiadiazole hybrid
Eman O. Osman, Heba Attia, Reham Samir, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135135-135135
Closed Access | Times Cited: 5
Synthesis and antimicrobial activity evaluation of pyrazole derivatives containing the imidazo[2,1‐b][1,3,4]thiadiazole moiety
Junda Qi, Yuqing Meng, Jingxin Sun, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 8
Closed Access | Times Cited: 5
Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer
Faustino Mollinedo, Consuelo Gajate
Cancers (2021) Vol. 13, Iss. 16, pp. 4173-4173
Open Access | Times Cited: 15
Synthesis, structural characterization, biological activity, and theoretical studies of some novel thioether‐bridged 2,6‐disubstituted imidazothiadiazole analogues
Hasan Tunel, Mustafa Er, Hakan Alıcı, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 6, pp. 1321-1343
Closed Access | Times Cited: 14
Bivalent Ni(II), Co(II) and Cu(II) complexes of [(E)-[(2-methyl-1,3-thiazol-5-yl)methylidene]amino]thiourea: synthesis, spectral characterization, DNA and in-vitro anti-bacterial studies
Basappa C. Yallur, P. Murali Krishna, Malathi Challa
Heliyon (2021) Vol. 7, Iss. 4, pp. e06838-e06838
Open Access | Times Cited: 14
Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
L. G. Akhuba, Z. G. Tigai, Dmitrii Shek
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 327-331
Open Access | Times Cited: 5
Synthesis, Characterization, Antimicrobial Evaluation, and Computational Investigation of Substituted Imidazo[2,1‐b][1,3,4]Thiadiazole Derivatives
Meltem Dagli, Mustafa Er, Tuncay Karakurt, et al.
ChemistrySelect (2020) Vol. 5, Iss. 38, pp. 11753-11763
Closed Access | Times Cited: 14
Harmine-inspired design and synthesis of benzo[d]imidazo[2,1-b]thiazole derivatives bearing 1,3,4-oxadiazole moiety as potential tumor suppressors
Tianming Zhao, Yang Yu, Jing Yang, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116367-116367
Closed Access | Times Cited: 13
Synthesis, Structure, and Magnetic and Biological Properties of Copper(II) Complexes with 1,3,4-Thiadiazole Derivatives
Lyudmila G. Lavrenova, Taisiya S. Sukhikh, Lyudmila A. Glinskaya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13024-13024
Open Access | Times Cited: 4
Matrix Metalloproteinases in Oral Cancer Pathogenesis and their Use in Therapy
S. Maurya, Divya Prasad, Sayali Mukherjee
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 3-17
Closed Access | Times Cited: 4
New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4
Dario P. Anobile, Mauro Niso, Adrián Puerta, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1682-1682
Open Access | Times Cited: 8
In vitro Mechanistic Exploration of Novel Spiropyrrolidine Heterocyclic Hybrids as Anticancer Agents
Raju Suresh Kumar, Abdulrahman I. Almansour, Natarajan Arumugam, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 12
Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway
Monika Szeliga, Monika Karpińska, Radosław Rola, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104362-104362
Closed Access | Times Cited: 10
Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1H-1,2,4-triazoles and 1-(Diarylmethyl)-1H-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer
Gloria Ana, Patrick Kelly, Azizah M. Malebari, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 169-169
Open Access | Times Cited: 9
3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations
Menna A. Ewida, Heba A. Ewida, Mahmoud S. Ahmed, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105205-105205
Closed Access | Times Cited: 9
Silencing of long non‑coding RNA SNHG15 suppresses proliferation, migration and invasion of pancreatic cancer cells by regulating the microRNA‑345‑5p/RAB27B axis
Pengfei Jiang, Youmin Yin, Yan Wu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 9
Novel Thioether‐Bridged 2,6‐Disubstituted and 2,5,6‐Trisubstituted Imidazothiadiazole Analogues: Synthesis, Antiproliferative Activity, ADME, and Molecular Docking Studies
Ibrahim Ozcan, Senem Akkoç, Hakan Alıcı, et al.
Chemistry & Biodiversity (2022) Vol. 20, Iss. 1
Closed Access | Times Cited: 6
Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
Aubrey L. Miller, Patrick L. Garcia, Tracy L. Gamblin, et al.
Cancer Drug Resistance (2020)
Open Access | Times Cited: 7
Recent synthetic strategies of medicinally important imidazothiadiazoles
Tooba Jabeen, Sana Aslam, Muhammad Yaseen, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101679-101679
Open Access | Times Cited: 2
Multi-step Synthesis of Novel Pyrazole Derivatives as Anticancer Agents
Amita Vyas, Kaushik S. Lunagariya, Ranjan C. Khunt
Polycyclic aromatic compounds (2023), pp. 1-14
Closed Access | Times Cited: 2
Synthesis, Structure, and Properties of Copper(II) Complexes with 2,5-Bis(Ethylthio)-1,3,4-Thiadiazole
Л. Г. Лавренова, Vladislav Yu. Komarov, L. A. Glinskaya, et al.
Journal of Structural Chemistry (2023) Vol. 64, Iss. 5, pp. 895-905
Closed Access | Times Cited: 2
Therapeutic Charisma of Imidazo [2,1-b] [1,3,4]-Thiadiazole Analogues: A Patent Review
Anuradha Mehra, Rekha Sangwan, Aryan Mehra, et al.
Pharmaceutical Patent Analyst (2023) Vol. 12, Iss. 4, pp. 177-191
Closed Access | Times Cited: 2

Scroll to top